'''''Following a recent warning from the US Food and Drug Administration (FDA) on the safety of certain ultrasound contrast agents (UCAs) containing polyethylene glycol (PEG), the American Institute of Ultrasound in Medicine (AIUM) joins the International ...'

'''''A steady procession of mobile health devices continues to march through the FDA’s regulatory process. The US Food and Drug Administration has granted Redmond, Washington-based mobile health start-up Mobisante 510(k) clearance for its smartphone-based ...'

'''''A Mesa medical device maker has received approval from the U.S. Food and Drug Administration to begin marketing its ultrasound technology to perform eyebrow lifts without surgery. Next, it hopes the same technology will be OK’d for other applications ...'

'''''Analogic Corp. (ALOG: Quote) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration or FDA for the handheld Sonic Window ultrasound system, an imaging device for visualizing vasculature and guiding peripheral ...'

'''''Echometrix, a Madison medical technology company, has received U.S. Food and Drug Administration approval to sell its EchoSoft ultrasound technology. We're very pleased to have reached this critical milestone, said chief executive Sam Adams. The ...'

'''''ScienceDaily (Apr. 1, 2008) — A Saint Louis University cardiologist called upon the U.S. Food and Drug Administration (FDA) on March 31 to reconsider a strong warning it recently placed on a diagnostic tool, stating that the warning could prevent doctors ...'

'''''The U.S. Food and Drug Administration (FDA) cleared software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is an accessory to compatible diagnostic ultrasound ...'

'''''On August 20, 2012, InSightec announced it received approval from the Food and Drug Administration (FDA) to begin Phase I clinical trials evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor-dominant Parkinson’s ...'

'''''Acusphere, Inc. (ACUS.PK), a specialty pharmaceutical company, today announced that it had reached an agreement with the U.S. Food & Drug Administration (FDA) regarding the design of a new Phase 3 study of the company’s lead product candidate, Imagify™ ...'

'''''The Food and Drug Administration is preparing to warn physicians about hazards with drugs used to enhance the diagnosis of heart problems using ultrasound imaging machines. A spokeswoman for the agency said it 'has been investigating reports of ...'